ID: ALA2011239

Max Phase: Preclinical

Molecular Formula: C21H25FN4O4

Molecular Weight: 416.45

Molecule Type: Small molecule

Representations

Canonical SMILES:  N#Cc1ccccc1OC[C@@H](O)CNCCNC(=O)Nc1cccc(OCC[18F])c1

Standard InChI:  InChI=1S/C21H25FN4O4/c22-8-11-29-19-6-3-5-17(12-19)26-21(28)25-10-9-24-14-18(27)15-30-20-7-2-1-4-16(20)13-23/h1-7,12,18,24,27H,8-11,14-15H2,(H2,25,26,28)/t18-/m0/s1/i22-1

Standard InChI Key:  BLWXVLQBJZIBSQ-IUMIREHHSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 416.45

Molecular Weight (Monoisotopic): 416.1860

AlogP: 2.06

#Rotatable Bonds: 12

Polar Surface Area: 115.64

Molecular Species: BASE

HBA: 6

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.10

CX Basic pKa: 8.79

CX LogP: 1.65

CX LogD: 0.25

Aromatic Rings: 2

Heavy Atoms: 30

QED Weighted: 0.39

Np Likeness Score: -1.66

References

1. Radeke HS, Purohit A, Harris TD, Hanson K, Jones R, Hu C, Yalamanchili P, Hayes M, Yu M, Guaraldi M, Kagan M, Azure M, Cdebaca M, Robinson S, Casebier D..  (2011)  Synthesis and Cardiac Imaging of (18)F-Ligands Selective for β1-Adrenoreceptors.,  2  (9): [PMID:24900360] [10.1021/ml1002458]

Source

Source(1):

• Scientific Literature